Tools & Techniques

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

How ATR-FTIR spectroscopy could lead to less invasive cancer prescreening

Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?

Artificial intelligence could have a huge impact on drug discovery.

Machine learning and DNA methylation could open up a new realm of diagnostic possibility

Data analysis in proteomics is not fit for purpose – but here’s how we can get on track

The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer

Is direct-to-consumer testing anywhere near as useful as it appears to the public – or to science?

As the profile of metabolomics soars, we offer our thoughts on the future of the field.

A review of FDA data suggests that women are now better represented in clinical trials.